ALGIERS - The Algerian-French Chamber of Commerce and Industry (CCIAF) and the Algerian Group of Stakeholders of the Digital Sector (GAAN) signed Thursday in Algiers an agreement to boost the export of Algerian digital services.
ALGIERS- The ministry of Health, Population and Hospital Reform said Monday that the Covid-19 vaccine is scheduled to arrive this month, pledging to "inform people as soon it is delivered."
ALGIERS- The minister of Health, Population and Hospital Reform, Pr. Abderrahmane Benbouzid, will pay a working visit to Mauritania on Monday, leading a medical mission made up of members of the scientific committee for coronavirus pandemic monitoring and many specialists and technicians, and carrying medical aid.
ALGIERS- Algeria has signed an agreement with a Russian laboratory to purchase Covid-19 vaccine, said Minister of Communication, Spokesman of the Government Ammar Belhimer.
ALGIERS- Algeria has implemented an “accelerated” registration procedure of the vaccine, affirmed Wednesday, in Algiers, Dr. Salah Eddine Sahraoui, chairman of the Algerian Company of Biotechnology and Medical Research, insisting on the continuation of other preventive measures, once the vaccination campaign starts in the country.
ALGIERS- Prime Minister Abdelaziz Djerad said Saturday that Algeria "will acquire an anti-coronavirus vaccine with strong guarantees," hence the need to avoid acting hastily or taking a random decision."
ALGIERS- General Manager of the National Medicines Agency (ANM), Kamel Mansouri said on Wednesday in Algiers that the availability of drugs out of stock in the Algerian market will "significantly improve" at the end of the month January 2021.
ALGIERS- The maternal mortality ratio (MMR) recorded in Algeria following a 2019 consolidation survey carried out in 2020 by the Ministry of Health, Population and Hospital Reform is 48.5 per 100,000 live births, the ministry’s manager for Population Ouali Amar announced Tuesday.
ALGIERS- The Ministry of Higher Education and Scientific Research announced Monday, in a statement, to freeze the opening of applications to the different residential abroad training programmes, because of the health situation related to Covid-19.
PARIS- A vaccine jointly developed by US firm Pfizer and German company BioNTech has proven to be 90% effective at preventing COVID-19 infections, according to phase 3 trials, the last step before an application for registration, announced these companies.